2021-01-11,5 Value Stocks To Watch In The Healthcare Sector
2021-01-05,Plus Therapeutics to Participate in Upcoming January Conferences
2020-12-15,Plus Therapeutics Completes Sixth Dosing Cohort in ReSPECT Glioblastoma Trial
2020-12-08,Plus Therapeutics to Present at 13th Annual LD Micro Main Event Conference
2020-12-01,Plus Therapeutics Expands ReSPECT Clinical Trial to MD Anderson Cancer Center
2020-11-19,Plus Therapeutics Announces Positive Interim Data from ReSPECT Phase 1 Clinical Trial in Recurrent Glioblastoma
2020-11-16,Plus Therapeutics to Participate in Upcoming November Investor Conferences
2020-11-13,Plus Therapeutics Announces Webinar to Present ReSPECT Glioblastoma Clinical Trial Update
2020-11-12,Plus Therapeutics to Present at the virtual Fall Investor Summit on November 16th-18th
2020-11-05,Plus Therapeutics Announces Formation of Scientific Advisory Board
2020-10-29,Plus Therapeutics Announces Initiation of Final Cohort of ReSPECT Glioblastoma Trial
2020-10-22,Plus Therapeutics Reports Third Quarter 2020 Financial Results and Business Highlights
2020-10-22,"Plus Therapeutics, Inc. to Host Earnings Call"
2020-10-15,Plus Therapeutics to Present at the Cancer Innovation Summit
2020-10-14,"Plus Therapeutics to Announce Third Quarter 2020 Financial Results and Host Conference Call on October 22, 2020"
2020-10-02,Plus Therapeutics Announces Brain Cancer Clinical Advisory Team
2020-10-01,ReSPECT Glioblastoma Clinical Trial Data to be Presented at 2020 Society for Neuro-Oncology Annual Meeting
2020-09-15,Plus Therapeutics Receives Fast Track Designation From FDA for Its Novel Glioblastoma Treatment
2020-09-09,"Plus Therapeutics, Inc. to Present at the 22nd H. C. Wainwright Annual Global Investor Conference on September 15, 2020"
2020-09-03,"Plus Therapeutics, Inc. to Present at the 9th Annual Gateway Conference on September 10, 2020"
2020-09-01,"Plus Therapeutics, Inc. receives FDA Orphan Drug Designation for its Novel Glioblastoma Treatment"
2020-08-28,"Plus Therapeutics, Inc. to Present at The LD 500 Virtual Conference"
2020-08-25,How Much Did Plus Therapeutics' (NASDAQ:PSTV) CEO Pocket Last Year?
2020-08-10,Plus Therapeutics Reports Second Quarter 2020 Financial and Business Results
2020-08-03,"Plus Therapeutics To Report Second Quarter Fiscal Year 2020 Financial Results And Corporate Update on August 10, 2020"
2020-07-28,Plus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT Glioblastoma Clinical Trial and Expands Trial Sites
2020-07-23,"Plus Therapeutics to Present at the YAFO Access China Partnering Conference on July 30, 2020"
2020-07-06,Plus Therapeutics Announces Inducement Stock Grants
2020-05-14,Plus Therapeutics Reports First Quarter 2020 Financial and Business Results
2020-05-12,Plus Therapeutics Announces Patient-Focused Presentation Supporting Brain Tumor Awareness Month
2020-05-11,Plus Therapeutics Announces Closing of Agreement To License Novel Oncology Platform
2020-05-07,"Plus Therapeutics To Report First Quarter Fiscal Year 2020 Financial Results and Corporate Update on May 14, 2020"
2020-04-16,Plus Therapeutics to Present at the Planet MicroCap Showcase Virtual Investor Conference 2020
2020-04-06,Plus Therapeutics Donates Personal Protective Equipment to Scripps Health to Confront COVID-19 Pandemic
2020-04-01,Plus Therapeutics Announces Dr. Gregory Stein as Head of Clinical Development
2020-03-30,Plus Therapeutics Reports Fourth Quarter and Full Fiscal Year 2019 Financial and Business Results
2020-03-30,"Plus Therapeutics, Inc. to Host Earnings Call"
2020-03-30,"Plus Therapeutics Licenses Novel Oncology Platform, Expands Pipeline"
2020-03-25,"Plus Therapeutics To Report Fourth Quarter and Full Fiscal Year 2019 Financial Results and Corporate Update on March 30, 2020"
2020-03-12,Plus Therapeutics Welcomes Two New Directors
2020-02-06,Plus Therapeutics Appoints Chief Financial Officer
2020-02-06,Plus Therapeutics Announces Changes to its Board of Directors
2020-01-06,Plus Therapeutics Shareholder Update: Transition Achieved in 2019; Poised for Expansion in 2020
2020-01-02,Plus Therapeutics Appoints Dr. An van Es-Johansson to Board of Directors
2019-12-09,Plus Therapeutics to Present at Biotech Showcase 2020
2019-11-25,Plus Therapeutics to Present at the LD Micro Main Event (XII)
2019-11-14,Plus Therapeutics Reports Third Quarter 2019 Financial and Business Results
2019-11-04,"Plus Therapeutics To Report Fiscal 2019 Third Quarter Financial Results and Corporate Update on November 14, 2019"
2019-10-15,Plus Therapeutics Receives $4.6MM Reimbursement Payment
2019-09-26,"Plus Therapeutics, Inc. Announces Closing of $15 Million Underwritten Public Offering"
2019-09-23,"Plus Therapeutics, Inc. Announces Pricing Of $15 Million Underwritten Public Offering"
2019-09-23,Plus Therapeutics to Receive $4.6MM Reimbursement Payment
